HPV Vaccination and Recurrence of Cervical Disease
Author Information
Author(s): Cao Qinxue, Hou Yantao, Wang Chaoyang, Yin Juntao
Primary Institution: Huaihe Hospital, Henan University, Henan, China
Hypothesis
Does HPV vaccination reduce the risk of HPV infection and recurrence of related diseases after local surgical treatment?
Conclusion
HPV vaccination after surgical excision does not reduce the risk of recurrent cervical high-grade squamous intraepithelial lesions (HSIL).
Supporting Evidence
- Eight randomized controlled trials were included in the analysis.
- The risk of cervical HSIL recurrence was not significantly reduced in vaccinated individuals.
- HPV vaccination showed some reduction in recurrence related to HPV types 16/18, but with high uncertainty.
- All studies were assessed as low risk of bias using the Cochrane RoB-2.0 tool.
- Vaccination timing did not significantly affect recurrence rates.
Takeaway
Getting the HPV vaccine after surgery doesn't help prevent the return of cervical problems caused by HPV.
Methodology
A systematic review and meta-analysis of randomized controlled trials assessing the effect of HPV vaccination on recurrence of cervical HSIL after local surgical treatment.
Potential Biases
Risk of bias assessed as low in all included studies.
Limitations
Variability in participant demographics, timing of vaccination, and follow-up duration across studies may affect results.
Participant Demographics
Participants included women treated for cervical lesions, with a mean age ranging from 18 to 55 years.
Statistical Information
P-Value
0.92
Confidence Interval
0.66–1.27
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website